Skip to main content

Table 1 Baseline characteristics and medication at discharge, early vs. late cohort

From: Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction

  Early (n = 23,447) Late (n = 24,227) P-value
Age (median) 70 (61–79) 70 (61–79) 0.08
Women% 33.5 33.7 0.89
Smoking% 23.1 22.2 0.02
Diabetes% 21.7 22.3 0.12
STEMIa% 36.9 37 0.9
Hypertension% 53 54.6 <0.001
Atrial fibrillation% 13.9 14.1 0.38
Heart failure during hospitalization% 20.2 18.9 <0.001
Previous MIb% 8.5 7.3 < 0.001
Previous ischemic stroke% 7.0 6.8 0.42
Previous hemorrhagic stroke% 1.1 1.3 0.08
Previous dialysis% 0.5 0.5 0.96
Previous PADc% 4.4 4.9 0.03
Thrombolysis during hospitalization% 1.7 1.2 <0.001
PCId during hospitalization% 71.1 75.4 <0.001
CABGe during hospitalization% 1.1 1.4 < 0.001
eGFRf 77.7 (60–90.8) 78.1 (60.2–91.2) 0.06
Aspirin 97 95.6 <0.001
ACEI/ARBg 78.6 79.8 <0.01
Statins 91.1 91.5 0.14
Oral anticoagulants 4.5 6.3 <0.001
Beta blockers 90.5 89.1 <0.001
Calcium inhibitors 15.3 16.2 0.01
Diuretics 26.4 23.5 <0.001
  1. aST-elevation myocardial Infarction
  2. bMyocardial infarction
  3. cPeripheral artery disease
  4. dPercutaneous coronary intervention
  5. eCoronary artery bypass graft surgery
  6. fEstimated glomerular filtration rate
  7. gACEI Angiotensin converting enzyme-inhibitors, ARB Angiotensin receptor blockers